Top 50 Biotech Startup Investors in Japan (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
SMBC Venture Capital
VC Fund
|
26 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $1.5M–$184M |
|
Mitsubishi UFJ Capital
VC Fund
|
24 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $1.2M–$198M |
|
ANRI
VC Fund
|
21 | Japan, United States, Indonesia | Seed, Series A | Software, Medical, Health Care | $413k–$41M |
|
UntroD Capital
VC Fund
|
20 | Japan, Singapore, Austria | Seed, Series A | Manufacturing, Biotechnology, Health Care | $772k–$90M |
|
Osaka University Venture Capital
VC Fund
|
18 | Japan | Seed, Series A | Biotechnology, Health Care, Medical | $1.8M–$49M |
|
Fast Track Initiative, Inc.
VC Fund
|
18 | Japan, United States, United Kingdom | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $345k–$117M |
|
Keio Innovation Initiative
VC Fund
|
14 | Japan, United Kingdom | Series A, Seed | Health Care, Medical, Biotechnology | $826k–$64M |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
13 | Japan, United States, India | Seed, Series A, Series B | Health Care, Biotechnology, Medical | $2.5M–$100M |
|
JAFCO
VC Fund
|
13 | Japan, United States, Israel | Series A, Series B | Information Technology, Software, Artificial Intelligence | $2.1M–$184M |
|
Mizuho Capital
VC Fund
|
12 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Artificial Intelligence | $2M–$269M |
|
SBI Investment
VC Fund
|
12 | Japan, South Korea, United States | Series B, Series A | Software, Information Technology, Financial Services | $2.3M–$142M |
|
Miyako Capital
VC Fund
|
10 | Japan, United States, United Kingdom | Series A, Seed, Series B | Medical, Biotechnology, Information Technology | $750k–$354M |
|
DBJ Capital
VC Fund
|
10 | Japan, United States, Australia | Series A, Series B | Software, Health Care, Biotechnology | $2.7M–$184M |
|
Japan Science and Technology Agency
VC Fund
|
9 | Japan | Series A, Seed | Biotechnology, Medical, Manufacturing | $1.7M–$255M |
|
Real Tech Japan
VC Fund
|
9 | Japan, Singapore, Austria | Seed, Series A | Manufacturing, Biotechnology, Robotics | $1.2M–$213M |
|
Nissay Capital
VC Fund
|
8 | Japan, United States, Ethiopia | Seed, Series A | Health Care, Information Technology, Medical | $565k–$71M |
|
DG Daiwa Ventures
VC Fund
|
8 | Japan, United States, India | Seed, Series A, Series B | Software, FinTech, Artificial Intelligence | $679k–$122M |
|
Nippon Venture Capital
VC Fund
|
7 | Japan, United States, Indonesia | Series A, Series B | Software, Health Care, Information Technology | $1.5M–$269M |
|
Angel Bridge
VC Fund
|
7 | Japan | Series A, Seed, Series B | Information Technology, Software, Consulting | $792k–$47M |
|
Miraidoa
VC Fund
|
7 | Japan, United States, Myanmar | Seed, Venture - Series Unknown | Manufacturing, Health Care, Information Technology | $186k–$16M |
|
IT-Farm
VC Fund
|
6 | United States, Japan, Germany | Seed, Series A | Software, Health Care, Medical | $1.5M–$16M |
|
Senshu Ikeda Capital
VC Fund
|
6 | Japan | Series A, Seed | Manufacturing, Software, Internet | $1M–$71M |
|
Kyogin Lease & Capital
VC Fund
|
5 | Japan | Series A, Seed | Manufacturing, Medical, Biotechnology | $91k–$61M |
|
Incubate Fund
VC Fund
|
5 | Japan, United States, India | Seed, Series A | Software, Information Technology, E-Commerce | $317k–$57M |
|
D3
VC Fund
|
5 | Japan, United States | Series A, Seed, Series B | Biotechnology, Therapeutics, Manufacturing | $690k–$51M |
|
FFG Venture Business Partners
VC Fund
|
5 | Japan, Indonesia, United States | Series A, Seed, Series B | Software, Health Care, Artificial Intelligence | $1M–$113M |
|
Global Brain Corporation
VC Fund
|
5 | Japan, United States, United Kingdom | Series A, Series B | Software, Information Technology, Artificial Intelligence | $2.4M–$109M |
|
Tsukuba Institute of Research
VC Fund
|
4 | Japan | Series A, Seed | Medical, Manufacturing, Biotechnology | $3M–$31M |
|
F-Prime
VC Fund
|
4 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $9.2M–$150M |
|
JIC Venture Growth Investments
VC Fund
|
4 | Japan, Singapore, United States | Series B, Series C | Information Technology, Software, Medical | $4.3M–$77M |
|
Delight Ventures
VC Fund
|
4 | Japan, United States, South Korea | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $577k–$283M |
|
Fujifilm
VC Fund
|
4 | Japan, United States, China | Series A, Corporate Round | Biotechnology, Health Care, Medical | $1.3M–$1.7B |
|
Daiwa Corporate Investment
VC Fund
|
4 | Japan, United States, France | Series A, Seed | Software, Manufacturing, Task Management | $2.8M–$71M |
|
Remiges Ventures
VC Fund
|
4 | United States, Japan, Canada | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $2.6M–$41M |
|
Eight Roads Ventures
VC Fund
|
3 | United States, China, India | Series B, Series A, Series C | Software, Health Care, Information Technology | $6.5M–$118M |
|
Capital Medica Ventures
VC Fund
|
3 | Japan | Series A, Seed | Medical, Health Care, Software | $403k–$51M |
|
QB Capital
VC Fund
|
3 | Japan, Singapore, United States | Seed, Series A | Manufacturing, Medical, Biotechnology | $641k–$213M |
|
Takeda
VC Fund
|
3 | United States, Japan, China | Grant, Corporate Round | Health Care, Biotechnology, Pharmaceutical | $5k–$1.4B |
|
KSP
VC Fund
|
3 | Japan | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Higin Capital
VC Fund
|
3 | Japan | Series A, Series B, Seed | Medical, Biotechnology, Software | $633k–$17M |
|
Universal Materials Incubator
VC Fund
|
3 | Japan, United States, India | Series A, Series B | Manufacturing, Biotechnology, Chemical | $2M–$99M |
|
Darwin Venture Management
VC Fund
|
3 | Taiwan, United States, Japan | Seed, Series A | Software, Manufacturing, Information Technology | $1M–$76M |
|
WASEDA University Ventures
VC Fund
|
3 | Japan, United States, United Kingdom | Seed, Series A, Convertible Note | Medical, Biotechnology, Information Technology | $1.2M–$38M |
|
Chushin Venture Capital
VC Fund
|
3 | Japan | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $955k–$128M |
|
Sosei CVC
VC Fund
|
3 | Japan | Series A, Series B | Biotechnology, Medical, Pharmaceutical | |
|
Chugin Capital Partner
VC Fund
|
3 | Japan | Series A, Seed, Series B | Manufacturing, Software, Information Technology | $246k–$54M |
|
Tokyo Century
VC Fund
|
3 | Japan, Singapore, United States | Series B, Series A | Software, Transportation, Robotics | $2M–$152M |
|
SBI Group
VC Fund
|
3 | Japan, United States, United Kingdom | Series A, Series B | Financial Services, FinTech, Information Technology | $2.8M–$142M |
|
Takeda Ventures
VC Fund
|
3 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $10M–$130M |
|
Tohoku University Venture Partners
VC Fund
|
3 | Japan | Series A, Venture - Series Unknown, Seed | Medical, Manufacturing, Biotechnology | $349k–$31M |
| Access all 626 investors in Japan Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 584
- Round size: Series A $1.5M–$106M; Series B $3.1M–$184M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Atom — Atom is a humanoid robot built platform. Its bipedal, dual-armed robots are designed not just as industrial tools but as collaborators that expand human capability. By combining advanced Physical AI—environmental perception, judgment, and action planning—with robust robotic hardware, Atom is creating adaptive agents capable of working acrossdiverse settings to augment or, where appropriate, replace human labor. The company positions these robots as a next step in societal evolution: a new class of machines that learn and behave in human-like ways to advance productivity, safety, and quality of life.
- Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 576
- Round size: Series A $1.2M–$74M; Series B $4.3M–$198M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
- WARPSPACE — ARPSPACE is a space startup originating from the University of Tsukuba, has been launching and working on a satellite development project at the University of Tsukuba for five years until the company was established.
- Luxna Biotech — Luxana Biotech is a biotechnology firm dedicated to promoting the practical use of safe and effective nucleic acid therapies. Utilizing nucleic acid chemistry technology, the company strives to provide nucleic acid medicines to patients suffering from diseases that currently lack effective treatments.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more...Investment focus
- Industry: Software, Medical, Health Care
- Stage:Seed, Series A
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 269
- Round size: Seed $413k–$19M; Series A $2.3M–$41M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — raised $102M in 2022
Portfolio highlights
- Any Style — Any Style develops a messaging app from voice actors that regularly sends messages via subscription. It also engages in the planning and production of audio content and the VTuber production business.
- Chaintope — Chaintope is specializes in blockchain technology with a focus for FinTech and non-FinTech sectors.
- Smile Robotics — Smile Robotics provides Service Robots in Japan.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 138
- Round size: Seed $772k–$28M; Series A $2.3M–$90M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
- Eco-Pork — Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite.
- IGrid Solutions — IGrid Solutions will promote “eDCM” to optimize power energy demand.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 89
- Round size: Seed $1.8M–$43M; Series A $3M–$49M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- LQUOM — QWAVE offers cryptography communication technology.
- Toregem BioPharma — Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 83
- Round size: Seed $345k–$117M; Series A $3M–$113M; Series B $9.5M–$91M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2021
Portfolio highlights
- NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
- Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 90
- Round size: Seed $826k–$50M; Series A $2.2M–$64M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- Starlight Engine — Starlight Engine develops and commercializes fusion energy power plant technologies.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, India
Investor stats
- Total investments: 195
- Round size: Seed $2.5M–$35M; Series A $2.8M–$64M; Series B $2.8M–$100M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- TXP Medical — TXP Medical build a next-generation medical system through acute care.
- Startbahn — Startbahn aims to realize a richer society by providing the technology needed by artists and people involved with art all over the world. We are developing Startbahn Cert., a service that issues blockchain certificates for artworks, and promoting the development of Startrail, a blockchain infrastructure that is the basis for Startbahn Cert. We alsorun joint projects with other companies.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 304
- Round size: Series A $2.1M–$142M; Series B $6.4M–$184M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
- Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
- Yokohama Vanilla — Yokohama Vanilla is a Company which operates Yokohama-based gift sweets brand.
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 477
- Round size: Series A $2M–$79M; Series B $2.1M–$269M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
- bestat — bestat is a developer of platforms for 3D data creation, management, and utilization using AI and offers digital twins services.
- FunPep — FunPep is an Industry-university collaboration bioventure company.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Series B, Series A
- Geography: Japan, South Korea, United States
Investor stats
- Total investments: 386
- Round size: Series A $2.3M–$142M; Series B $5.3M–$142M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2020
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
- Direava — Direava is a medical device company that manufactures, sells, leases, and maintains medical equipments along with consulting services.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $750k–$43M; Series A $4.8M–$50M; Series B $3.7M–$354M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2019
Portfolio highlights
- Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Japan, United States, Australia
Investor stats
- Total investments: 160
- Round size: Series A $2.7M–$85M; Series B $4.6M–$184M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Creattura — Creatura assists companies in reducing greenhouse gas emissions by generating and distributing carbon credits and promoting the adoption of renewable energy sources.
- Scohia Pharma — Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.
- Arrowsmith — Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of bacterial infectious diseases. Through transformative science, Arrowsmith strive to create a world free from the pain and fear caused by antimicrobial resistance.
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Medical, Manufacturing
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 54
- Round size: Seed $1.7M–$50M; Series A $2.3M–$255M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Triorb — The corporate website of TriOrb Inc., revolutionizing production lines with our ball-driven omnidirectional mobility platform.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- Solaris — Solaris commercializes, manufactures, and sells soft robotics using pneumatic artificial muscles. Solaris was founded in 2017 and was headquartered in Tokyo, Japan.
Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Robotics
- Stage:Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 79
- Round size: Seed $1.2M–$43M; Series A $6M–$213M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 264
- Round size: Seed $565k–$43M; Series A $2M–$71M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Welyco — Welyco is an information technology company.We operate smart restaurant "solto". Utilize IT to realize efficient and diverse restaurant management.
- Toranotec — TORANOTEC CORPORATION aims to create a world where investment is familiar to everyone by realizing "from consumption to investment" through the services of asset management subsidiaries , utilizing advanced technology.
- Zeal Boxing Fitness — Zeal Boxing Fitness combines power of sports with the power of technology to provide a service that allows to enjoy fitness.
DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, India
Investor stats
- Total investments: 85
- Round size: Seed $679k–$7M; Series A $3M–$103M; Series B $6.5M–$122M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Listie — Listie is an industrial engineering company that develops, supplies, and maintains lithium separation equipment and membranes. It is an important infrastructure resource that supports modern life, including electric vehicles, smartphones, and renewable energy storage.
- Dioseve — Dioseve is providing novel possibilities for all life.
- BEAM Technologies — BEAM Technologies, focuses on developing optical semiconductor devices using special light to offer clean solutions to ecosystem-related problems.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 172
- Round size: Series A $1.5M–$74M; Series B $3.3M–$269M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $278M in 2023
Portfolio highlights
- Space BD — Space BD aims to become a one-stop shop to respond to all issues related to industrialization of space, and alleviate the work of businesses that are developing new technologies.
- KUZEN — KUZEN provides enterprise-grade chatbot technologies, especially the bot framework and NLP, via a visual UI without coding. The company is utilizing technology to develop a system that broadens the scope of dialogue. They use technology to provide their customers with next-generation standard procedures that broaden the possibilities ofconversation, resulting in unprecedented business practices.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more...Investment focus
- Industry: Information Technology, Software, Consulting
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 73
- Round size: Seed $792k–$28M; Series A $2.5M–$19M; Series B $6.5M–$47M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $152M in 2019
Portfolio highlights
- Recerqa — Recerqa is a supply chain management SaaS that utilizes advanced development technology and AI to improve the purchasing, inventory, and sales management experiences.
- Mign — Mign offers a generative AI-related SaaS solutions for the construction and real estate fields.
- Henry — Henry develops and provides a cloud-based electronic medical record and receipt system for small and medium-sized hospitals.
Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Japan, United States, Myanmar
Investor stats
- Total investments: 154
- Round size: Seed $338k–$16M; Venture - Series Unknown $186k–$3.5M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $36M in 2020
Portfolio highlights
- Sinumy — Sinumy develops touchless identity authentication technology and high-speed, high-precision position measurement technology.
- Dioseve — Dioseve is providing novel possibilities for all life.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfoliocompanies, especially on the partnership with Japanese enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Japan, Germany
Investor stats
- Total investments: 126
- Round size: Seed $1.5M–$7.5M; Series A $1.6M–$16M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Ubitus — As cloud gaming enablers, Ubitus' GPU virtualization, Streaming technology and hybrid cloud deployment can serve different kinds of solutions for Telco, Game companies to quick enter cloud gaming market. Moreover, Ubitus provide Global distribution and New Media content solution for new media studio and fashion brand to help them distribute rich media contents worldwide.
- POPS Worldwide — POPS Worldwide is the leading digital entertainment company in Southeast Asia. With over 4 billion monthly views of its music and entertainment content, POPS is the fastest growing digital entertainment media company with hundreds of artists, content creators and partners from broadcast television, publishing and production in the POPS Network.POPS also produces a wide variety of original content for its industry-leading owned and operated channels like POPS Music, POPS Kids, POPS TV, Beauty Me, HerVoice and CoolTV that target highly sought after demographics: teens, kids, women and men.
- Global Equipment Services — As a strategic partner to developers of multi-sector products, Averna provides innovative automated testing tool and quality assurance solutions.
Senshu Ikeda Capital offers financial consultancy services.
Show more...Investment focus
- Industry: Manufacturing, Software, Internet
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 66
- Round size: Seed $1M–$61M; Series A $1.9M–$71M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $177M in 2019
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
- LEP — LEP develops plants that glow without electricity.
Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.
Show more...Investment focus
- Industry: Manufacturing, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 31
- Round size: Seed $91k–$61M; Series A $5.6M–$57M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- TSK Corporation — TSK is a manufacturing company that develops organic synthesis technology to supply innovative and long-lasting catalysts to industries. The company develops and manufactures iron catalysts that are used in the production of agrochemicals, semiconductors, and pharmaceuticals, giving enterprises the option of switching from palladium catalysts tomore environmentally friendly iron catalysts.
- IKOU — IKOU is an inclusive brand for babies and children that creates products valued by all users. The company's featured products include portable seats, bibs, and children's clothing products along with online services.
- Towing — Towing is an agricultural company that provides farming, manufacturing, and recycling services.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 313
- Round size: Seed $317k–$17M; Series A $2.4M–$57M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $2.4B in 2021
Portfolio highlights
- Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
- Black Cat Carnival — Black Cat Carnival Inc. is a communication service development company.
- Carbon CryoCapture — Carbon CryoCapture specializes in the carbon dioxide separation systems aimed at creating economically viable, energy-efficient, and genuinely sustainable CO2 separation and recovery technologies. The company is dedicated to deploying cost-effective, efficient systems for CO2 capture that integrate smoothly with current infrastructures, all whileenhancing energy consumption and production. This enables clients to attain zero emissions throughout the development and application of resources.
DISCOVERY, DEVELOPMENT, DEPLOYMENT FOR GLOBAL HEALTH, WITH SCIENCE & BUSINESS ACUMEN
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Japan, United States
Investor stats
- Total investments: 12
- Round size: Seed $1.6M–$2.8M; Series A $690k–$51M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Neumo — Neumo is a musical education-based firm that offers pitch measurement courses, programs, consulting, and tests.
- RevolKa — RevolKa manufactures bio-products pharmaceuticals intended to serve the healthcare sector.
- Neros Technologies — Neros is vertically integrating production of unmanned defense systems in the United States, securing the autonomous supply chain. Are you with us?
FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Japan, Indonesia, United States
Investor stats
- Total investments: 87
- Round size: Seed $1M–$50M; Series A $1.2M–$37M; Series B $4.3M–$113M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $691M in 2020
Portfolio highlights
- MW — MW is a smart home solution company that develops smart residential physical AI, robotics, and home design services.
- InsightX — InsightX is a technology platform focused on empowering businesses by simplifying complex processes and enabling smarter, more personalized user experiences.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Global Brain Corporation is a venture capital firm that invests in companies from seed or early to pre-IPO startups. Global Brain has invested in 300+ startups from seed/early to pre-IPO startups and achieved 25 IPOs and 61 M&As as a result of providing hands-on support services and resources to its portfolio startups. Global Brain hasmanaged a pure investment fund as well as multiple corporate venture capital funds partnered together with tier 1 public companies of telecom, real estate development, financial service, beverages, agriculture food, logistics, and electronic devices.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 677
- Round size: Series A $2.4M–$63M; Series B $4.3M–$109M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Eyeota — Engage your best customers with trusted audience data | enrich insights, enhance personalization and transform audience targeting.
- Moi — Moi Corporation was founded to deliver on the promise of the Twitcasting social live streaming platform. We developed Twitcasting to enable people to stream and share live video anytime, anywhere - connecting the world in real-time. TwitCasting provides a live streaming social platform that enables real-time chat between broacasters andviewers, through apps or desktop. Users can follow their favorite broadcasters and receive notifications when new a new live stream is about to start. Broadcasters can save and publish their live streams for later viewing.In early 2014 we added "Collabo" to Twitcasting, enabling as many as 6 users to broadcast together, in a single display. Viewers can join a broadcast that is already streaming live and broadcast together. It is the first app to support multi-device broadcasting in a single stream on mobile and PC. Our user base has doubled every year, and hit 7.5 million in September, 2014. While the largest part of our base is in Asia, users in US, Brazil, Mexico and other Latin American countries are now growing rapidly. About 70% of our users are under 25 years old, & approximately 95% of broadcasters shoot on mobile. 
- Deeping Source — Real-time Video Analytics based on Data Anonymization. High-accuracy computer vision for large-scale spaces: hypermarkets, shopping malls, convention centers, hospitals, logistics warehouses, construction sites, etc.
Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.
Show more...Investment focus
- Industry: Medical, Manufacturing, Biotechnology
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 8
- Round size: Series A $3M–$31M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
- Celaid Therapeutics — Celaid Therapeutics develops technologies and products based on hematopoietic stem cell (HSC) expansion and gene-augmented therapies. The company operates a platform that enables in-vitro propagation of human HSCs without relying on animal-derived components, facilitating scalability, consistency, and cost control. It applies this platform acrossworkflows, including donor/patient cell collection, HSC expansion, cell processing, and gene editing to deliver cell therapy products. Celaid advances pipelines in areas such as blood cancers, genetic disorders, and rare hematologic diseases. Through partnerships and internal research, it seeks to support both reagent/media supply and therapeutic development around HSC-based regenerative medicine.
- Veneno Technologies — Veneno Technologies develops drug candidates for pharmaceutical companies. The company provides services that include the treatment of neurological, cardiovascular, and metabolic diseases, cancer cell proliferation, metastasis, and immune cell regulation.
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 456
- Round size: Series A $9.2M–$100M; Series B $15M–$112M; Series C $22M–$150M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Sironax — Sironax is a pharmaceuticals company for inflammatory and neuro-degenerative diseases.
- Axle Health — Axle Health provides scheduling and workforce management software to help home healthcare and hospice providers improve their clinician productivity.
- Mersana Therapeutics — Discover how Day One is disrupting the status quo of traditional drug development to bring new medicines to children and adults with cancer.
JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses.JIC Venture Growth Investments was established in July 2020 and isbased in Tokyo, Japan.
Show more...Investment focus
- Industry: Information Technology, Software, Medical
- Stage:Series B, Series C
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 105
- Round size: Series B $4.7M–$52M; Series C $4.3M–$77M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
- Turing — Turing develops and manufactures fully autonomous vehicles.
- Atom — Atom is a humanoid robot built platform. Its bipedal, dual-armed robots are designed not just as industrial tools but as collaborators that expand human capability. By combining advanced Physical AI—environmental perception, judgment, and action planning—with robust robotic hardware, Atom is creating adaptive agents capable of working acrossdiverse settings to augment or, where appropriate, replace human labor. The company positions these robots as a next step in societal evolution: a new class of machines that learn and behave in human-like ways to advance productivity, safety, and quality of life.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Delight Ventures is a venture capital firm that thoroughly reduces the hurdles of entrepreneurship in Japan and supports entrepreneurs in the world. Entrepreneurship is taken as a natural career path, and we aim to be a society where both successful and unsuccessful people can continue to take on challenges.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, South Korea
Investor stats
- Total investments: 85
- Round size: Seed $577k–$26M; Series A $3.3M–$28M; Series B $3.1M–$283M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2019
Portfolio highlights
- Ababa — Ababa provides recruitment and employment solutions.
- CraftBank — CraftBank, Inc. is the start-up that operates online matching platform between constructors with having relations with 22k specialty constructors (10% coverage in the market). The company was succeeded in Management BuyOut in April 2021.
- Josh Collaboration — Josh Collaboration is a software company that provides mailing, fax transmission, and partner management services.
Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Corporate Round
- Geography: Japan, United States, China
Investor stats
- Total investments: 25
- Round size: Series A $15M–$425M; Corporate Round $1.3M–$1.7B
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Ripcord — Ripcord turns documents into powerful data. As a disruptor in the document intelligence market, Ripcord’s AI-driven platform harnesses proprietary robotics, generative AI, and cloud software to digitize and accurately derive vital information from paper and digital documents. Founded out of NASA research, Ripcord is backed by leading investorsincluding Kleiner Perkins, Google Ventures, Icon Ventures, Lux Capital, MUIP, and Apple co-founder Steve Wozniak.
- Rapidus — Rapidus is an Electronic component research, development, design, production, and sales that includes semiconductor elements and integrated circuits. Environmentally friendly, energy-saving semiconductors and semiconductor manufacturing technology are being researched and developed. Human resource development and training for the semiconductorsector.
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Daiwa Corporate Investment is a private investment firm of Daiwa Securities Group that has been engaged in overseas VC investments by taking advantage of an extensive business network in Japan and foreign countries, long experience and professional knowledge, and by supporting the growth of a number of overseas portfolio companies and their stockexchange listings.
Show more...Investment focus
- Industry: Software, Manufacturing, Task Management
- Stage:Series A, Seed
- Geography: Japan, United States, France
Investor stats
- Total investments: 135
- Round size: Seed $2.8M–$14M; Series A $3.1M–$71M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $1.5B in 2018
Portfolio highlights
- NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
- AstroX — AstroX is a private space startup company that develops satellite launch vehicles for space development. It utilizes the rockoon method for developing launch vehicles and small rockets to help clients easily use space.
- Sonire Therapeutics — SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future.
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, Japan, Canada
Investor stats
- Total investments: 24
- Round size: Seed $2.6M–$10M; Series A $6.6M–$25M; Series B $8.2M–$41M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $95M in 2019
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series B, Series A, Series C
- Geography: United States, China, India
Investor stats
- Total investments: 381
- Round size: Series A $6.5M–$62M; Series B $8.5M–$85M; Series C $15M–$118M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- GoodData.AI — GoodData is a leading composable data and analytics platform. Build, embed, and scale analytics on demand, with zero vendor lock-in.
- specsmakers — Buy Eyeglasses, Eyeglass Frames, Computer Glasses, Contact Lenses, Sunglasses online at Specsmakers. Latest Collection of Frames. Free Shipping. Secure checkout. 14 Days Return Policy.
- Oriental Qiyin — Oriental Qiyin is a professional autism rehabilitation center in China dedicated to the development of children's speech and intelligence.
Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.
Show more...Investment focus
- Industry: Medical, Health Care, Software
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 16
- Round size: Seed $403k–$17M; Series A $1.5M–$51M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- A-SEEDS — A-SEEDS, an innovative biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions.
- Do. Sukasu — Do. Sukasu is a software company that specializes in the development of visual space perception ability for brain science approaches.
- HEAL-lll — HEAL-lll is a multifaceted firm that merges healthcare, technology, and gamification to promote individual and organizational well-being.
QB Capital is make equity investments in venture companies.
Show more...Investment focus
- Industry: Manufacturing, Medical, Biotechnology
- Stage:Seed, Series A
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 54
- Round size: Seed $641k–$35M; Series A $1.3M–$213M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $429M in 2015
Portfolio highlights
- Equmenopolis — We dispatch conversational AI agents to schools and workplaces to improve creativity and productivity.
- Mechano Cross — Mechano Cross is a mechanical company that offers mechanochemical organic synthesis technology for solution reactions.
- Surv Biopharma — Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Grant, Corporate Round
- Geography: United States, Japan, China
Investor stats
- Total investments: 61
- Round size: Grant $5k–$8.7M; Corporate Round $52M–$1.4B
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- BaseLaunch — We partner with scientists and entrepreneurs to help launch and grow exceptional biotech ventures, developing cutting-edge therapeutics.
- Beacon Biosignals — AI + EEG to change the way patients are treated for disorders of the brain.
- Innovent Biologics — Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. Theregistered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.
KSP, Inc. is the core business entity responsible for operating the Kanagawa Science Park (KSP) and has accepted the challenge of creating new industries through the support, development, and incubation of venture businesses. We provide a variety of business support services that best meet the needs of venture businesses in each stage of theirbusiness growth, ranging from the processes of startup and growth to public offerings. Several hundreds of new startup companies have been created and nurtured since its foundation. An incubation manager (IM) acts as a coordinator and provides a variety of support services to a venture company to help them successfully launch and develop their new business, such as offering individual consultations and a variety of information or advice. KSP, Inc. is well poised to cope with the varying needs of new ventures for highly sophisticated, specialized tasks by offering a business school, business support center, business matching services, and investment funds.The public sector, such as the Kanagawa prefectural government, Kawasaki city government, and the Development Bank of Japan, Inc., has an equity participation in KSP, thus playing a vital role in the deployment of local industrial development policy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 36
- Lead/follow: no public data
Portfolio highlights
- 3DC — 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices.
- THE PHAGE — The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels.
- Mira Robotics — Mira Robotics is a software based company provide services that can robots in various fields.
Higegin Capital is a venture capital firm.
Show more...Investment focus
- Industry: Medical, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: Japan
Investor stats
- Total investments: 27
- Round size: Seed $633k–$5.4M; Series A $1.2M–$9.1M; Series B $3.8M–$17M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $137M in 2020
Portfolio highlights
- Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
- EUV Photon — EUV Photon is an irradiation services company that conducts processing, evaluation, and measurement of materials for EUV lights.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Universal Materials Incubator Co., Ltd. is venture capital firm specializing in materials and chemical industry investments. The firm was established on October, 2015 and is headquartered in Tokyo, Japan
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Chemical
- Stage:Series A, Series B
- Geography: Japan, United States, India
Investor stats
- Total investments: 38
- Round size: Series A $2M–$17M; Series B $2.8M–$99M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $1.3B in 2019
Portfolio highlights
- Polyuse — Polyuse Co., Ltd. is developing technology centered on "3D printers for construction" for the construction and civil engineering industries under the mission of "updating the construction industry with the power of technology".
- EF Polymer — EF Polymer Private Limited providing 100% Organic and fully Biodegradable Super Absorbent Polymer cum Fertilizer to reduce Water and Fertilizer requirement for your plant. Let's grow organically.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Taiwan, United States, Japan
Investor stats
- Total investments: 146
- Round size: Seed $1M–$3.1M; Series A $3M–$76M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Phamily — Full-service care transformation powered by 10+ years of experience, a dedicated clinical workforce, and our AI-enabled platform.
- BitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
- PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
WASEDA University Ventures (WUV) is a venture capital firm specialising in founding investments by creating new start-up companies that make use of academia and are based on "the practical application of scholarship". Our mission is to be a capitalist that implements academic knowledge and
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Seed, Series A, Convertible Note
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $1.2M–$38M; Series A $1.3M–$14M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Neubond — Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous assistance and therapy during daily activities, integrating rehabilitation into the patient's daily life regardless of their motor capabilities. Neubond's solutions are designed to be intuitive and effective, aiming to improve thequality of life for individuals undergoing rehabilitation.
- Pestalozzi Technology — Pestalozzi Technology is a development and provision of educational products in the fields of physical education and club activities.
- Gel-Coat Biomaterials — Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies.
Chushin Venture Capital is a venture capital fund established by Kyoto Chuo Shinkin Bank.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 16
- Round size: Seed $1.5M–$2M; Series A $955k–$128M; Series B $5.1M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nexta — Nexta manufactures site, issues such as analog management, personalization of operations & labor shortages are becoming more serious.
- OOYOO — OOYOO Co., Ltd. is a DeepTech venture that combines international entrepreneurial spirit, and a 'Made In Japan' excellence, to bring the latest innovations in clean technology to society for a smarter, cleaner, and more mobile world.
- Toregem BioPharma — Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.
Sosei CVC is support the creation and growth of life science companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Pharmaceutical
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Junten Bio — JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.
- Chromocenter — Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
- Noile-Immune Biotech — Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
Chugin Capital Partner is a venture capital firm that invests in startups and business succession.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 27
- Round size: Seed $246k–$7.1M; Series A $1.2M–$4M; Series B $5.9M–$54M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- KG Motors — KG Motors is an automotive firm that manufactures electric vehicles that can be moved comfortably and safely by one person.
- xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
- Pixie Dust Technologies — Pixie Dust Technologies is a developer of computational technologies, including its ultrasonic phased array system with which one can generate force in mid-air; transport things in mid-air without touching anything; target and deliver different sounds from person to person in a crowd; direct guide-dogs; and even apply this in agricultural farming.
Tokyo Century is a diversified leasing business (leasing, installment sales, and other financial services for IT-related equipment, industrial equipment, and other machinery and facilities). Tokyo Century has various types of financing and is an international business.
Show more...Investment focus
- Industry: Software, Transportation, Robotics
- Stage:Series B, Series A
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 34
- Round size: Series A $2M–$152M; Series B $3.8M–$12M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- KAICO — KAICO is a pharmaceuticals, diagnostic drugs production company.
- PXP — We are Japanese green tech startup company established in 2020 aiming to realize clean energy that can be used freely by anyone, anywhere and anytime.
- Flat Collaboration — Flat Collaboration provides neutral, white-label hotel management for a diverse portfolio of luxury and lifestyle properties.
SBI Group aims to become a corporate entity that provides a variety of one-stop financial services over the Internet now that two major events, the Financial Big Bang resulting from deregulation, and the Internet Revolution resulting from IT innovation, have radically transformed the financial industry.
Show more...Investment focus
- Industry: Financial Services, FinTech, Information Technology
- Stage:Series A, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 155
- Round size: Series A $2.8M–$142M; Series B $7M–$62M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Gauntlet — Gauntlet builds a blockchain simulation and testing platform for financial systems. The company's blockchain simulation and the testing platform run a series of simulations to test the client's protocol or smart contract and gain intuition on how design choices affect behavior, thereby helping financial institutions by providingtransparency and greatly reduces the cost of experimentation so that teams can rapidly design, launch, and scale new decentralized systems. Gauntlet was founded in 2018 and is headquartered in Brooklyn, NY, USA.
- DriveWealth — DriveWealth, the global fintech investment rail and pioneer of fractional equities trading, is a visionary technology company that empowers more than 100 partners around the world to engage their customers by placing the markets in the palm of their hands. We believe the future is fractional, transactional, and mobile. Every mobile device should bea gateway to accessing investing and savings products, services, advice, and assistance for global citizens of all ages, wealth stages, and levels of financial expertise. DriveWealth’s consultative support and cloud based, modern technology platform allow partners to seamlessly offer branded investing experiences to drive customer acquisition, loyalty, retention, and revenue growth.
- NOT A HOTEL — NOT A HOTEL develops a vacation-home ownership and hospitality platform that enables customers to purchase usage rights to architect-designed homes and access a network of properties through a shared ownership model. The company offers vacation residences that can be purchased in increments based on annual usage, with ownership providing recurringaccess to the selected property and reciprocal use of other participating NOT A HOTEL properties. Its platform combines real estate ownership, hospitality operations, property management, reservations, concierge services, and digital tools that allow owners to manage stays, check in, and access services through a mobile application. NOT A HOTEL also provides hotel-style accommodation to guests and manages properties on behalf of owners, including maintenance, cleaning, and operational services. The company collaborates with architects, designers, and other creators to develop individually designed residences and is expanding its hospitality offering through additional properties and hotel brands.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 104
- Round size: Series A $10M–$58M; Series B $20M–$130M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
- Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
- Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
THVP is a venture capital corporation for startup innovation. It was established in 2015 and is based in Nagoya, Japan.
Show more...Investment focus
- Industry: Medical, Manufacturing, Biotechnology
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Japan
Investor stats
- Total investments: 31
- Round size: Seed $929k–$2.7M; Series A $349k–$31M; Venture - Series Unknown $1.3M–$8.8M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Koeda — KOEDA is researching and developing medical devices that are safe, painless, and easy to use for acute cholecystitis. KOEDA will transform the management of cholecystitis. So far, endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) has been a notably difficult procedure carried out by skilled doctors at specific advanced centers. Althoughinserting a tube into the gallbladder is less invasive, it is complex, and there may be concerns regarding bile leakage. By combining clinical expertise with precision engineering, KOEDA addresses a clearly defined medical need in a growing global market and is currently moving forward on schedule for regulatory clearance and commercialization.
- Scohia Pharma — Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.
- Storyline — Storyline is a company that use technology and design to address social challenges while building a sustainable society.
Biotech Investor funding in Japan at a glance
Stats across 555 deals from 626 investors.
Access all 626 investors in Japan Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in Japan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 626 investors investing in Japan Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!